Marimed (MRMD) Accumulated Expenses (2012 - 2026)

Marimed (MRMD) has 14 years of Accumulated Expenses data on file, last reported at $10.4 million in Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 34.0% year-over-year to $10.4 million in Q1 2026; TTM through Mar 2026 was $10.4 million, a 34.0% increase from a year earlier, with the FY2025 full-year figure at $9.5 million, up 114.41% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $10.4 million, up from $9.5 million in the prior quarter.
• Over the last five years, Accumulated Expenses for MRMD reached as high as $10.4 million in Q1 2026 and fell as low as $1.7 million in Q1 2022.
• Historically, Accumulated Expenses has averaged $5.0 million across 5 years, with a median of $4.4 million in 2024.
• Across the five-year window, Accumulated Expenses sank 70.57% in 2022 and surged 114.41% in 2025, its largest moves.
• Year by year, Accumulated Expenses stood at $3.1 million in 2022, then increased by 14.82% to $3.5 million in 2023, then gained by 24.96% to $4.4 million in 2024, then jumped by 114.41% to $9.5 million in 2025, then climbed by 8.92% to $10.4 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $10.4 million in Q1 2026, $9.5 million in Q4 2025, and $2.7 million in Q3 2025.